Navigation Links
Linkwell Corporation Year-End 2007 Earnings Release and Conference Call Notice

SHANGHAI, China, April 8, 2008 /Xinhua-PRNewswire-FirstCall/ -- Linkwell Corporation (Linkwell or the Company) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, today announced it will discuss its 2007 year-end financial results in a conference call on Wednesday, April 16, 2008, at 8:30 a.m. EDT.

The Company will release its 2007 year-end financial results on Tuesday, April 15, 2008. Hosting the call will be Linkwell Chairman and CEO Xuelian Bian, COO Arthur Huang, Corporate Secretary Rick Wang and investor relations consultant Craig Bird.

Conference Call

To participate in the conference call, callers from the USA and Canada please dial 800-257-2101, all other international callers please dial (303)-262-2130. All callers should dial in five to ten minutes prior to the conference call time.

Audio Stream and Webcast

You may also participate via live audio stream by logging onto . A rebroadcast of the audio stream will be available using the same web link for 90 days after the initial broadcast.

Linkwell also announced the revised dates for its non-deal road show in the USA to April 16-22, 2008. Investors interested in meeting with Linkwell COO, Mr. Arthur Huang should contact investor relations, Craig Bird, at (215)-885-4981.

About Linkwell Corporation

Linkwell Corporation develops, manufactures and distributes disinfectant healthcare products in China through its subsidiary Shanghai LiKang Disinfectant High Tech Company ("LiKang"). Linkwell's disinfectant healthcare products are a nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectants in liquid, tablet, powder and aerosol form. Through LiKang, Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China. For more information, please visit .

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products, pricing and new technology; changes in consumer preferences and tastes; effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production; and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Investor Relations

Craig Bird

Segue Ventures LLC

Tel: +1-215-885-4981


SOURCE Linkwell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K
2. Shanghai Disinfection Association and Linkwell Corporation Co-Establish the Shanghai Disinfection Association Laboratory Center
3. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
4. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
5. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 8:00am ET
6. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
7. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET
8. Pet DRx Corporation Reports 2007 Financial Results
9. Dialysis Corporation of America Announces the Development of a New Facility in Pennsylvania
10. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
11. Mach One Corporation Announces Completion of Final Tests Prior to Full Scale Production
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator ... the latest addition to the devices for sale in the United States. Clarity ... and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... has selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s ... including CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica ...
(Date:12/1/2015)... ... 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has ... The order will be from the China Disabled Persons’ Federation, a central government association, ... solution for children and adults suffering from severe and profound hearing loss . ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani Inc., announced ... (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled the training ... solutions targeted to the high-end enterprise contact center marketplace. , Ed Kapelinski, President ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Trevor and Taylor ... as they play for the chance to represent the United States. This hybrid ... to be a part of their journey in addition to offering corporate sponsors with ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Sweden , December 1, 2015 ... Cancer Study Group (IBCSG, Bern ) and ... to be part of a state of the art trial, ... --> --> The study, ... treated with anti-hormonal therapy in combination with palbociclib, a cancer ...
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
(Date:11/30/2015)... Asia,s largest exhibition and conference dedicated to the Medical Device ... 22 nd April 2016. --> --> ... --> -->   --> --> ... population and the government back up, the Medical Device is one of the ... . With the aging population and the government back up, the Medical ...
Breaking Medicine Technology: